Richard Decker's Colleagues at TCR2 Therapeutics
Richard Decker's Contact Details
HQ
617-949-5200
617-949-5200
Location
Greater Boston
Greater Boston
Company
TCR2 Therapeutics
TCR2 Therapeutics
Richard Decker's Company Details
TCR² Therapeutics Inc. is a clinical-stage cell therapy company developing a pipeline of novel T cell therapies for patients suffering from solid tumors. The company is focused on the discovery and development of product candidates against novel and complex targets utilizing its proprietary T cell receptor (TCR) Fusion Construct T cells (TRuC®-T cells). The TRuC platform is designed to specifically recognize and kill cancer cells by harnessing signaling from the entire TCR, independent of human leukocyte antigens (HLA). For more information about TCR², please visit www.tcr2.com.
Frequently Asked Questions about Richard Decker
Richard Decker currently works for TCR2 Therapeutics.
Richard Decker's role at TCR2 Therapeutics is Scientist, Molecular Biology.
Richard Decker's email address is ***@tcr2.com. To view Richard Decker's full email address, please signup to ConnectPlex.
Richard Decker works in the BioTech/Drugs industry.
Richard Decker's colleagues at TCR2 Therapeutics are Joshua Daniel, Angela Avrami, Emily Dale, Robert Crayton, Fahima C., Rowland Lees, Robin Olden and others.
Richard Decker's phone number is 617-949-5200